Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2730-6011
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of CDKN2A/B, MTAP, and TERT Genetic Alterations on Survival in IDH Wild Type Glioblastomas ; volume:13 ; number:1 ; day:15 ; month:11 ; year:2022 ; pages:1-13 ; date:12.2022
Discover oncology ; 13, Heft 1 (15.11.2022), 1-13, 12.2022
- Creator
-
Hsu, Eric J.
Thomas, Jamie
Maher, Elizabeth A.
Youssef, Michael
Timmerman, Robert D.
Wardak, Zabi
Dan, Tu D.
Patel, Toral R.
Vo, Dat T.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12672-022-00590-2
- URN
-
urn:nbn:de:101:1-2023012809052274452806
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hsu, Eric J.
- Thomas, Jamie
- Maher, Elizabeth A.
- Youssef, Michael
- Timmerman, Robert D.
- Wardak, Zabi
- Dan, Tu D.
- Patel, Toral R.
- Vo, Dat T.
- SpringerLink (Online service)
Other Objects (12)
TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival
TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: a report of the RANO resect group
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations
Performance of adjuvant treatment correlates with survival in reoperated glioblastomas
TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival
TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: a report of the RANO resect group
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations
Performance of adjuvant treatment correlates with survival in reoperated glioblastomas
TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
Heterogeneity of DNA methylation profiles and copy number alterations in 10782 adult-type glioblastomas, IDH-wildtype
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions
IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation
Perfusion CT detects alterations in local cerebral flow of glioma related to IDH, MGMT and TERT status
neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies IDH wild-type glioblastomas with the longest survival
TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: a report of the RANO resect group
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas
The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma
The prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations